425: Strive Details Semler Merger Risks & Outlook

Strive, Inc. has reposted a communication outlining forward-looking statements and significant risks associated with its proposed business combination with Semler Scientific, Inc.

Summary

• Strive, Inc. and Semler Scientific, Inc. are pursuing a proposed business combination.
• The communication, reposted by Strive's CMO on December 17, 2025, serves as a cautionary statement regarding forward-looking statements.
• Forward-looking statements include expectations for the transaction's strategic and financial benefits, impact on future financial performance, closing timing, and successful integration.
• Investors are cautioned against relying too heavily on forward-looking statements due to inherent risks and uncertainties.
• The filing directs stakeholders to additional SEC documents, including Strive's Form S-4 filed on December 3, 2025, and respective Form 10-Qs.

Sentiment

Score: 5

Explanation: The filing is a standard regulatory disclosure of a proposed merger, emphasizing risks and forward-looking statements. It's neutral in tone, as required by regulatory filings, but the extensive list of risks prevents a higher score, while the underlying strategic intent of a merger prevents a lower one.

Positives

• The proposed transaction aims to achieve strategic and financial benefits for the combined company.
• Management anticipates a positive impact on the combined company's future financial performance.

Negatives

• The proposed transaction may not close as expected or at all.
• Anticipated benefits, including cost savings and strategic gains, may not be realized.
• Integration of the two companies could be more difficult, time-consuming, or costly than expected.
• The transaction may be more expensive or take longer to complete than anticipated.
• Management's attention may be diverted from ongoing business operations.
• Potential for adverse reactions from customers or changes to business/employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing could occur.

Risks

• The merger agreement between Strive and Semler Scientific could be terminated.
• Conditions required for closing the proposed transaction may not be received or satisfied on a timely basis or at all.
• Legal proceedings may be instituted against Strive, Semler Scientific, or the combined company.
• Anticipated benefits, including cost savings and strategic gains, may not be realized due to changes in or problems arising from Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could negatively impact the realization of benefits.
• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other unknown or unpredictable factors could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The companies anticipate strategic and financial benefits from the proposed transaction, expecting a positive impact on the combined company's future financial performance. However, these are forward-looking statements subject to significant risks and uncertainties, including the successful integration of businesses and the realization of anticipated cost savings and strategic gains.

Management Comments

• Strive and Semler Scientific believe that their expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of their existing knowledge of their business and operations.

Industry Context

This filing does not provide specific industry context beyond the mention of "Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets," which suggests involvement in or exposure to the digital asset space, potentially aligning with broader trends of corporate adoption of digital assets.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is a risk factor.

Stakeholder Impact

• Shareholders: Potential dilution from Strive's issuance of Class A common stock; need to vote on the proposed transaction.
• Customers: Potential adverse reactions from Strive's or Semler Scientific's customers.
• Employees: Potential changes to business or employee relationships.
• Management: Diversion of management's attention from ongoing business operations and opportunities.

Next Steps

• Strive has filed a Registration Statement on Form S-4, which includes an Information Statement/Proxy Statement/Prospectus.
• A definitive Information Statement/Proxy Statement/Prospectus was sent to Semler Scientific stockholders to seek approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus and other relevant SEC documents before making voting or investment decisions.

Key Dates

Keywords

Strive Inc, Semler Scientific, Merger, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Risk Factors, Corporate Governance, Digital Assets, Bitcoin Treasury, Share Dilution